Use this URL to cite or link to this record in EThOS:
Title: Apoptotic B cells : their interactions with macrophages and modulation by rituximab
Author: Herrington, Felicity
ISNI:       0000 0004 5347 4293
Awarding Body: University of Glasgow
Current Institution: University of Glasgow
Date of Award: 2014
Availability of Full Text:
Access from EThOS:
Access from Institution:
Apoptotic cells (AC) are able to modulate the immune system, dampening inflammation and triggering anti-inflammatory responses by various immune cells as a consequence of interaction and uptake. Rituximab (RTX) is an anti-CD20 monoclonal antibody used as a treatment in several autoimmune diseases, including rheumatoid arthritis (RA). Treatment results in B cell depletion, with B cell apoptosis known to contribute to RTX-mediated B cell death. However the simple removal of B cells from the system does not seem to account for all the beneficial effects of this biologic. We propose that RTX treatment in RA results in the re-establishment of temporary tolerance to the system, through an apoptotic B cell-dependent mechanism. Initial in vitro and in vivo investigations were undertaken to explore the validity of this hypothesis. The present work sought to examine the immunomodulatory capacity of apoptotic B cells and to determine whether the potential anti-inflammatory effects of apoptotic B cells are modulated by RTX, with both in vitro methods and an in vivo model of autoimmunity utilized in these studies. The results presented in this thesis demonstrate that apoptotic B cells have comparable effects on bone marrow derived macrophage (BMDM) phenotype and function in vitro as previously described AC from other cellular sources. Surprisingly, in the in vitro assay system used, viable cells had the same immunomodulatory effects on BMDM as AC, for all criteria investigated. Preliminary studies indicate this may be a promising avenue of inquiry, however further work is needed before a conclusion can be reached as to the relative level of involvement of apoptotic B cell-mediated tolerance in the improvement seen on RTX treatment in RA.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: QR180 Immunology